Evidence map›Paper›PMID 33202744›Full record

ReviewInternational journal of molecular sciences2020

Review: Ischemia Reperfusion Injury-A Translational Perspective in Organ Transplantation.

André Renaldo Fernández, Rodrigo Sánchez-Tarjuelo, Paolo Cravedi, Jordi Ochando, Marcos López-Hoyos

Registry-linked trialAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06395259 (Evaluation of the Oxidative Status of Patients Undergoing Solid Organs Transplantation), which is not on this map. Cited by 73 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06395259 active not recruitingnot on this mapstarted 2023, after this paper: background citation

Evaluation of the Oxidative Status of Patients Undergoing Solid Organs Transplantation: Observational Study

TypeobservationalSponsorPoliclinico HospitalRan2023 to 2024Enrolled40ConditionsTransplantation, Ascorbic Acid Deficiency
3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

André Renaldo FernándezResearch Institute-IDIVAL, 39011 Santander, Spain.
Rodrigo Sánchez-TarjueloDepartment of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Paolo CravediDepartment of Medicine, Division of Nephrology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.ORCID 0000-0001-7837-0923
Jordi OchandoDepartment of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Marcos López-HoyosResearch Institute-IDIVAL, 39011 Santander, Spain.ORCID 0000-0003-0562-427X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thanks to the development of new, more potent and selective immunosuppressive drugs together with advances in surgical techniques, organ transplantation has emerged from an experimental surgery over fifty years ago to being the treatment of choice for many end-stage organ diseases, with over 139,000 organ transplants performed worldwide in 2019. Inherent to the transplantation procedure is the fact that the donor organ is subjected to blood flow cessation and ischemia during harvesting, which is followed by preservation and reperfusion of the organ once transplanted into the recipient. Consequently, ischemia/reperfusion induces a significant injury to the graft with activation of the immune response in the recipient and deleterious effect on the graft. The purpose of this review is to discuss and shed new light on the pathways involved in ischemia/reperfusion injury (IRI) that act at different stages during the donation process, surgery, and immediate post-transplant period. Here, we present strategies that combine various treatments targeted at different mechanistic pathways during several time points to prevent graft loss secondary to the inflammation caused by IRI.

Indexed as

Organ PreservationOrgan TransplantationAnimalsHumansImmunosuppressive AgentsReperfusion InjuryImmunosuppressive Agentscell deathcell metabolismhypoxiainnate immunityischemia reperfusion injuryRNA interference

Identifiers

PMID33202744
PMCPMC7696417

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.